for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Prestige Consumer Healthcare Inc

PBH

Latest Trade

36.64USD

Change

1.25(+3.53%)

Volume

434,844

Today's Range

35.27

 - 

36.71

52 Week Range

27.40

 - 

46.12

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
35.39
Open
35.59
Volume
434,844
3M AVG Volume
7.76
Today's High
36.71
Today's Low
35.27
52 Week High
46.12
52 Week Low
27.40
Shares Out (MIL)
50.10
Market Cap (MIL)
1,773.17
Forward P/E
10.97
Dividend (Yield %)
--

Next Event

Q3 2021 Prestige Consumer Healthcare Inc Earnings Release

Latest Developments

More

Prestige Consumer Healthcare Q2 Earnings Per Share $0.88

Prestige Consumer Healthcare Q1 Earnings Per Share $0.86

Prestige Consumer Healthcare Reports Fiscal 2020 Q4 And Full-Year Results

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc., formerly Prestige Brands Holdings, Inc. is engaged in the marketing, sales and distribution of over-the-counter healthcare products. The Company operates through two segments: North American Over-the-Counter (OTC) Healthcare, and International Over-the-Counter Healthcare. Its portfolio of OTC healthcare products includes core brands, such as DenTek specialty oral care products, Monistat women's health products, Nix lice treatment, Chloraseptic sore throat treatments, Clear Eyes eye care products, Compound W wart treatments, The Doctor's NightGuard dental protector, Little Remedies pediatric over-the-counter products, Efferdent denture care products, Luden's throat drops, Dramamine motion sickness treatment, BC and Goody's pain relievers, Beano gas prevention, Debrox earwax remover, and Gaviscon antacid.

Industry

Retail (Drugs)

Contact Info

660 White Plains Rd

TARRYTOWN, NY

10591-5139

United States

+1.914.5246800

http://prestigebrands.com

Executive Leadership

Ronald M. Lombardi

Chairman of the Board, President, Chief Executive Officer

Christine Sacco

Chief Financial Officer

Adel Mekhail

Executive Vice President - Sales and Marketing

William C. PPool

Senior Vice President, General Counsel and Corporate Secretary

Jeffrey Zerillo

Senior Vice President, Operations

Key Stats

2.29 mean rating - 7 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

1.0K

2019

1.0K

2020

1.0K

2021(E)

0.9K
EPS (USD)

2018

2.580

2019

2.780

2020

2.960

2021(E)

3.180
Price To Earnings (TTM)
11.00
Price To Sales (TTM)
1.85
Price To Book (MRQ)
1.39
Price To Cash Flow (TTM)
9.14
Total Debt To Equity (MRQ)
121.98
LT Debt To Equity (MRQ)
121.77
Return on Investment (TTM)
4.94
Return on Equity (TTM)
4.74

Latest News

Latest News

BRIEF-Prestige Consumer Healthcare Reports Fiscal 2020 Q4 And Full-Year Results

* Q4 REVENUE $251.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $239.8 MILLION

BRIEF-Prestige Brands Holdings Q4 Adjusted Earnings Per Share $0.62

* PRESTIGE BRANDS HOLDINGS, INC. REPORTS FISCAL 2018 FOURTH QUARTER AND FULL YEAR RESULTS; PROVIDES FISCAL 2019 OUTLOOK

BRIEF-Prestige Brands Announces Successful Repricing Of Term Loan Facility

* PRESTIGE BRANDS HOLDINGS, INC. ANNOUNCES SUCCESSFUL REPRICING OF TERM LOAN FACILITY AND PRICING OF ADD-ON OFFERING OF SENIOR NOTES DUE 2024

BRIEF-Prestige Brands Holdings, Inc. Announces Launch Of Add-On Offering Of Senior Notes Due 2024

* PRESTIGE BRANDS HOLDINGS, INC. ANNOUNCES LAUNCH OF ADD-ON OFFERING OF SENIOR NOTES DUE 2024

BRIEF-Prestige Brands Reports Q3 Adjusted Earnings Per Share $0.70

* PRESTIGE BRANDS HOLDINGS, INC. REPORTS FISCAL 2018 THIRD QUARTER RESULTS

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up